142 related articles for article (PubMed ID: 24470591)
1. Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists.
Yakimchuk K; Hasni MS; Guan J; Chao MP; Sander B; Okret S
Blood; 2014 Mar; 123(13):2054-61. PubMed ID: 24470591
[TBL] [Abstract][Full Text] [Related]
2. Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo.
Yakimchuk K; Iravani M; Hasni MS; Rhönnstad P; Nilsson S; Jondal M; Okret S
Leukemia; 2011 Jul; 25(7):1103-10. PubMed ID: 21502954
[TBL] [Abstract][Full Text] [Related]
3. How do estrogens control lymphoma?
Roemer K; Pfreundschuh M
Blood; 2014 Mar; 123(13):1980-1. PubMed ID: 24677401
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor β ligation inhibits Hodgkin lymphoma growth by inducing autophagy.
Pierdominici M; Maselli A; Locatelli SL; Ciarlo L; Careddu G; Patrizio M; Ascione B; Tinari A; Carlo-Stella C; Malorni W; Matarrese P; Ortona E
Oncotarget; 2017 Jan; 8(5):8522-8535. PubMed ID: 28052027
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts.
Hartman J; Lindberg K; Morani A; Inzunza J; Ström A; Gustafsson JA
Cancer Res; 2006 Dec; 66(23):11207-13. PubMed ID: 17145865
[TBL] [Abstract][Full Text] [Related]
6. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor-β activation in combination with letrozole blocks the growth of breast cancer tumors resistant to letrozole therapy.
Nair HB; Kirma NB; Ganapathy M; Vadlamudi RK; Tekmal RR
Steroids; 2011 Jul; 76(8):792-6. PubMed ID: 21477609
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of estrogen biosynthesis enhances lymphoma growth in mice.
Talaber G; Yakimchuk K; Guan J; Inzunza J; Okret S
Oncotarget; 2016 Apr; 7(15):20718-27. PubMed ID: 26943574
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer.
Liu J; Viswanadhapalli S; Garcia L; Zhou M; Nair BC; Kost E; Rao Tekmal R; Li R; Rao MK; Curiel T; Vadlamudi RK; Sareddy GR
Oncotarget; 2017 Jul; 8(30):50002-50014. PubMed ID: 28654894
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor β selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells.
Zhang B; Zhang CG; Ji LH; Zhao G; Wu ZY
J Gastroenterol Hepatol; 2018 Mar; 33(3):747-755. PubMed ID: 28884481
[TBL] [Abstract][Full Text] [Related]
11. Adult female wildtype, but not oestrogen receptor beta knockout, mice have decreased depression-like behaviour during pro-oestrus and following administration of oestradiol or diarylpropionitrile.
Walf AA; Koonce CJ; Frye CA
J Psychopharmacol; 2009 Jun; 23(4):442-50. PubMed ID: 18562442
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia Upregulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α-Dependent Manner.
Frump AL; Selej M; Wood JA; Albrecht M; Yakubov B; Petrache I; Lahm T
Am J Respir Cell Mol Biol; 2018 Jul; 59(1):114-126. PubMed ID: 29394091
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Receptor β (ESR2) Transcriptome and Chromatin Binding in a Mantle Cell Lymphoma Tumor Model Reveal the Tumor-Suppressing Mechanisms of Estrogens.
Huang D; Huang Z; Indukuri R; Bangalore Revanna C; Berglund M; Guan J; Yakimchuk K; Damdimopoulos A; Williams C; Okret S
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804870
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic significance of estrogen receptor β agonists in gliomas.
Sareddy GR; Nair BC; Gonugunta VK; Zhang QG; Brenner A; Brann DW; Tekmal RR; Vadlamudi RK
Mol Cancer Ther; 2012 May; 11(5):1174-82. PubMed ID: 22442308
[TBL] [Abstract][Full Text] [Related]
15. Lenalidomide inhibits lymphangiogenesis in preclinical models of mantle cell lymphoma.
Song K; Herzog BH; Sheng M; Fu J; McDaniel JM; Chen H; Ruan J; Xia L
Cancer Res; 2013 Dec; 73(24):7254-64. PubMed ID: 24158094
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor beta signaling in CD8
Yuan B; Clark CA; Wu B; Yang J; Drerup JM; Li T; Jin VX; Hu Y; Curiel TJ; Li R
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462142
[TBL] [Abstract][Full Text] [Related]
17. Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis.
Weissmann M; Arvatz G; Horowitz N; Feld S; Naroditsky I; Zhang Y; Ng M; Hammond E; Nevo E; Vlodavsky I; Ilan N
Proc Natl Acad Sci U S A; 2016 Jan; 113(3):704-9. PubMed ID: 26729870
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells.
Carlo-Stella C; Locatelli SL; Giacomini A; Cleris L; Saba E; Righi M; Guidetti A; Gianni AM
PLoS One; 2013; 8(4):e61603. PubMed ID: 23620775
[TBL] [Abstract][Full Text] [Related]
19. Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells.
Sotoca AM; van den Berg H; Vervoort J; van der Saag P; Ström A; Gustafsson JA; Rietjens I; Murk AJ
Toxicol Sci; 2008 Oct; 105(2):303-11. PubMed ID: 18644836
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.
Zhao L; Huang S; Mei S; Yang Z; Xu L; Zhou N; Yang Q; Shen Q; Wang W; Le X; Lau WB; Lau B; Wang X; Yi T; Zhao X; Wei Y; Warner M; Gustafsson JÅ; Zhou S
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3673-E3681. PubMed ID: 29592953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
